Search - tctmd.com

Displaying 341 - 360 of 375

Sort: Relevancy | Date

News Daily News

PRODIGY Published: No Advantage to Long-term Clopidogrel

April 03, 2012

News Daily News

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Caitlin E. Cox

March 06, 2012

News Daily News

MISTRAL: No Lasting Benefit from Early Abciximab in STEMI Patients

Caitlin E. Cox

February 09, 2012

News Daily News

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

Caitlin E. Cox

January 26, 2012

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Daily News

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Jason Kahn

October 24, 2011

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Daily News

STEMI Patients Benefit From Clopidogrel Given Prior to PCI Center

Caitlin E. Cox

September 28, 2011

News Daily News

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

September 21, 2011

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Halting Clopidogrel in First Year Following Acute MI Hazardous

September 01, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Caitlin E. Cox

July 08, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

June 09, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

Advertisement

PRODIGY Published: No Advantage to Long-term Clopidogrel

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

MISTRAL: No Lasting Benefit from Early Abciximab in STEMI Patients

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Six Months Sufficient for Dual Antiplatelet Therapy

STEMI Patients Benefit From Clopidogrel Given Prior to PCI Center

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

ESC Congress 2011: Drugs, Devices Work Together

Halting Clopidogrel in First Year Following Acute MI Hazardous

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content